Annotation Detail for TAGLN3
Basic Information
Top
Desease ID | Desease Name |
---|
2069 | Schizophrenia |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TAGLN3 mRNA | affects expression | 16483693
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of TAGLN3 mRNA | increases expression | 18180321
|
C010176 |
halofuginone |
halofuginone results in increased expression of TAGLN3 mRNA | increases expression | 17180598
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.30 | 18287403 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.35 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.42 | 17123778 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.73 | 17123778 |
MESH:D006965 |
Hyperplasia |
|
halofuginone |
5.90 | 11874485 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.56 | 16393666 |
MESH:D008103 |
Liver Cirrhosis |
|
halofuginone |
4.24 | 17180598 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
halofuginone |
2.98 | 11172339 18458672 14739098 16489207 12175628 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
4.56 | 11399458 16427766 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.73 | 11985600 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
4.69 | 10548101 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.69 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.34 | 16740699 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.53 | 10548101 |
MESH:D012871 |
Skin Diseases |
|
halofuginone |
3.59 | 11874485 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.72 | 16684133 16045194 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.88 | 14652134 |
PharmGKB Accession:PA134896732
Releated disease ID |
Related disease Name |
PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |